Pesquisas alternativas:
doses devel » dose level (Expandir a Pesquisa), doses seven (Expandir a Pesquisa), doses derived (Expandir a Pesquisa)
dose levels » noise levels (Expandir a Pesquisa)
does devel » does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa), does bilevel (Expandir a Pesquisa)
doses devel » dose level (Expandir a Pesquisa), doses seven (Expandir a Pesquisa), doses derived (Expandir a Pesquisa)
dose levels » noise levels (Expandir a Pesquisa)
does devel » does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa), does bilevel (Expandir a Pesquisa)
1
Por Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Publicado no Drug Des Devel Ther (2017)
“... is related to the dose-dependent signal, while the degree of protection is related to the concentration...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Gahr, Maximilian, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Lepping, Peter, Freudenmann, Roland W
Publicado em 2011
“... pharmacological profile, including single dosing, predominantly renal excretion, low drug–drug interaction risk...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Kim, Hyungsub, Choi, Hee Youn, Kim, Yo-Han, Bae, Kyun-Seop, Jung, Jina, Son, Hankil, Lim, Hyeong-Seok
Publicado no Drug Des Devel Ther (2018)
“... that effectively reduces low-density lipoprotein cholesterol levels. However, statin monotherapy does not always...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Mumoli, Laura, Palleria, Caterina, Gasparini, Sara, Citraro, Rita, Labate, Angelo, Ferlazzo, Edoardo, Gambardella, Antonio, De Sarro, Giovambattista, Russo, Emilio
Publicado no Drug Des Devel Ther (2015)
“... requires dose adjustment. BRV does not seem to influence other antiepileptic drug plasma levels. Six...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Mok, Chi Chiu
Publicado em 2013
“... for the treatment of rheumatoid arthritis (RA) that does not respond adequately to disease-modifying antirheumatic...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Blandizzi, Corrado, Viscomi, Giuseppe Claudio, Scarpignato, Carmelo
Publicado no Drug Des Devel Ther (2014)
“... was specifically prepared for the study and formulated as the marketed product. Two doses (200 mg and 400 mg...”Publicado no Drug Des Devel Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Guo, Yan, Sun, Juan, Ye, Juan, Ma, Wenyu, Yan, Hualing, Wang, Gang
Publicado no Drug Des Devel Ther (2016)
“...), S. tridactyla Sch. Bip.-derived polysaccharides and flavones low-dose group, and S. tridactyla Sch. Bip.-derived...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Darkovska-Serafimovska, Marija, Janevik-Ivanovska, Emilija, Djorgoski, Icko, Arsova-Sarafinovska, Zorica, Zdravkovska, Milka, Balkanov, Trajan, Ugresic, Nenad
Publicado no Drug Des Devel Ther (2016)
“... aggregometer. Binding of (99m)Tc-tirofiban to platelets was evaluated. Serum levels of unlabeled (a validated...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Doupis, John
Publicado em 2014
“... reduction, typically ranging from 0.6% to 0.8% depending on baseline levels. In addition...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... that undergoes primarily renal elimination and does not affect cytochrome P450 enzymes. Assays to quantify...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo